Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Imaging G-Ratio in Multiple Sclerosis Using High-Gradient Diffusion MRI and Macromolecular Tissue Volume.

Yu F, Fan Q, Tian Q, Ngamsombat C, Machado N, Bireley JD, Russo AW, Nummenmaa A, Witzel T, Wald LL, Klawiter EC, Huang SY.

AJNR Am J Neuroradiol. 2019 Nov;40(11):1871-1877. doi: 10.3174/ajnr.A6283. Epub 2019 Nov 6.

2.

High-gradient diffusion MRI reveals distinct estimates of axon diameter index within different white matter tracts in the in vivo human brain.

Huang SY, Tian Q, Fan Q, Witzel T, Wichtmann B, McNab JA, Daniel Bireley J, Machado N, Klawiter EC, Mekkaoui C, Wald LL, Nummenmaa A.

Brain Struct Funct. 2019 Sep 28. doi: 10.1007/s00429-019-01961-2. [Epub ahead of print]

PMID:
31563995
3.

Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging.

Herranz E, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Mangeat G, Loggia ML, Cohen-Adad J, Klawiter EC, Sloane JA, Mainero C.

Mult Scler. 2019 Aug 1:1352458519867320. doi: 10.1177/1352458519867320. [Epub ahead of print]

PMID:
31368404
4.

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC).

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 28;6(5):e583. doi: 10.1212/NXI.0000000000000583. eCollection 2019 Sep.

5.

Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.

Huang SY, Fan Q, Machado N, Eloyan A, Bireley JD, Russo AW, Tobyne SM, Patel KR, Brewer K, Rapaport SF, Nummenmaa A, Witzel T, Sherman JC, Wald LL, Klawiter EC.

Ann Clin Transl Neurol. 2019 Mar 30;6(5):882-892. doi: 10.1002/acn3.760. eCollection 2019 May.

6.

Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET.

Barletta VT, Herranz E, Treaba CA, Ouellette R, Mehndiratta A, Loggia ML, Klawiter EC, Ionete C, Jacob SA, Mainero C.

Mult Scler. 2019 Apr 11:1352458519843048. doi: 10.1177/1352458519843048. [Epub ahead of print]

PMID:
30973800
7.

Age-related alterations in axonal microstructure in the corpus callosum measured by high-gradient diffusion MRI.

Fan Q, Tian Q, Ohringer NA, Nummenmaa A, Witzel T, Tobyne SM, Klawiter EC, Mekkaoui C, Rosen BR, Wald LL, Salat DH, Huang SY.

Neuroimage. 2019 May 1;191:325-336. doi: 10.1016/j.neuroimage.2019.02.036. Epub 2019 Feb 18.

PMID:
30790671
8.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30787160
9.

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators.

N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583.

10.

Movement measurements at home for multiple sclerosis: walking speed measured by a novel ambient measurement system.

Smith VM, Varsanik JS, Walker RA, Russo AW, Patel KR, Gabel W, Phillips GA, Kimmel ZM, Klawiter EC.

Mult Scler J Exp Transl Clin. 2018 Jan 23;4(1):2055217317753465. doi: 10.1177/2055217317753465. eCollection 2018 Jan-Mar.

11.

High risk of postpartum relapses in neuromyelitis optica spectrum disorder.

Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, Paul F, Cross AH, Jacobs A, Chitnis T, Weinshenker B.

Neurology. 2017 Nov 28;89(22):2238-2244. doi: 10.1212/WNL.0000000000004681. Epub 2017 Nov 1.

12.

In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.

Granberg T, Fan Q, Treaba CA, Ouellette R, Herranz E, Mangeat G, Louapre C, Cohen-Adad J, Klawiter EC, Sloane JA, Mainero C.

Brain. 2017 Nov 1;140(11):2912-2926. doi: 10.1093/brain/awx247. Erratum in: Brain. 2018 Feb 1;141(2):e14.

13.

Scan-rescan of axcaliber, macromolecular tissue volume, and g-ratio in the spinal cord.

Duval T, Smith V, Stikov N, Klawiter EC, Cohen-Adad J.

Magn Reson Med. 2018 May;79(5):2759-2765. doi: 10.1002/mrm.26945. Epub 2017 Oct 10.

14.

Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis.

Tobyne SM, Ochoa WB, Bireley JD, Smith VM, Geurts JJ, Schmahmann JD, Klawiter EC.

Mult Scler. 2018 Nov;24(13):1687-1695. doi: 10.1177/1352458517730132. Epub 2017 Sep 21.

PMID:
28933672
15.

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.

Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, Weinshenker B, Jacob A, Klawiter EC, Chitnis T.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 24;4(3):e339. doi: 10.1212/NXI.0000000000000339. eCollection 2017 May.

16.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative.

Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11. Review.

PMID:
27834394
17.

Neuroinflammatory component of gray matter pathology in multiple sclerosis.

Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C.

Ann Neurol. 2016 Nov;80(5):776-790. doi: 10.1002/ana.24791. Epub 2016 Oct 25.

18.

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A.

Contemp Clin Trials. 2016 Sep;50:166-77. doi: 10.1016/j.cct.2016.08.009. Epub 2016 Aug 10.

19.

A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.

Tobyne SM, Boratyn D, Johnson JA, Greve DN, Mainero C, Klawiter EC.

Hum Brain Mapp. 2016 Aug;37(8):2849-68. doi: 10.1002/hbm.23214. Epub 2016 May 24.

20.

Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging.

Huang SY, Tobyne SM, Nummenmaa A, Witzel T, Wald LL, McNab JA, Klawiter EC.

Radiology. 2016 Jul;280(1):244-51. doi: 10.1148/radiol.2016151582. Epub 2016 Feb 9.

21.

In vivo mapping of human spinal cord microstructure at 300mT/m.

Duval T, McNab JA, Setsompop K, Witzel T, Schneider T, Huang SY, Keil B, Klawiter EC, Wald LL, Cohen-Adad J.

Neuroimage. 2015 Sep;118:494-507. doi: 10.1016/j.neuroimage.2015.06.038. Epub 2015 Jun 19.

22.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

23.

MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH; Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository.

Neurology. 2015 Mar 17;84(11):1165-73. doi: 10.1212/WNL.0000000000001367. Epub 2015 Feb 18. Review.

24.

Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.

Klawiter EC, Ceccarelli A, Arora A, Jackson J, Bakshi S, Kim G, Miller J, Tauhid S, von Gizycki C, Bakshi R, Neema M.

J Neuroimaging. 2015 Jan-Feb;25(1):62-7. doi: 10.1111/jon.12124. Epub 2014 May 9.

25.

Current and new directions in MRI in multiple sclerosis.

Klawiter EC.

Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1058-73. doi: 10.1212/01.CON.0000433283.00221.37. Review.

26.

Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.

Naismith RT, Xu J, Klawiter EC, Lancia S, Tutlam NT, Wagner JM, Qian P, Trinkaus K, Song SK, Cross AH.

Neurology. 2013 Jun 11;80(24):2201-9. doi: 10.1212/WNL.0b013e318296e8f1. Epub 2013 May 10.

27.

CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.

Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT, Cross AH.

Mult Scler. 2013 Aug;19(9):1204-8. doi: 10.1177/1352458512473362. Epub 2013 Jan 15.

28.

Improved in vivo diffusion tensor imaging of human cervical spinal cord.

Xu J, Shimony JS, Klawiter EC, Snyder AZ, Trinkaus K, Naismith RT, Benzinger TL, Cross AH, Song SK.

Neuroimage. 2013 Feb 15;67:64-76. doi: 10.1016/j.neuroimage.2012.11.014. Epub 2012 Nov 21.

29.

Association of neuromyelitis optica with severe and intractable pain.

Qian P, Lancia S, Alvarez E, Klawiter EC, Cross AH, Naismith RT.

Arch Neurol. 2012 Nov;69(11):1482-7.

30.

Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis.

Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH.

Mult Scler. 2012 Sep;18(9):1259-68. doi: 10.1177/1352458512436593. Epub 2012 Feb 21.

31.

Clinical reasoning: A young adult presents with focal weakness and hemorrhagic brain lesions.

Virmani T, Agarwal A, Klawiter EC.

Neurology. 2011 May 31;76(22):e106-9. doi: 10.1212/WNL.0b013e31821d748a. No abstract available.

32.

Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords.

Klawiter EC, Schmidt RE, Trinkaus K, Liang HF, Budde MD, Naismith RT, Song SK, Cross AH, Benzinger TL.

Neuroimage. 2011 Apr 15;55(4):1454-60. doi: 10.1016/j.neuroimage.2011.01.007. Epub 2011 Jan 13.

33.

Spinal cord ring enhancement in multiple sclerosis.

Klawiter EC, Benzinger T, Roy A, Naismith RT, Parks BJ, Cross AH.

Arch Neurol. 2010 Nov;67(11):1395-8. doi: 10.1001/archneurol.2010.271.

34.

Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.

Klawiter EC, Piccio L, Lyons JA, Mikesell R, O'Connor KC, Cross AH.

Arch Neurol. 2010 Sep;67(9):1102-8. doi: 10.1001/archneurol.2010.197.

35.

The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?

Klawiter EC, Cross AH, Naismith RT.

Neurology. 2009 Sep 22;73(12):984-90. doi: 10.1212/WNL.0b013e3181b9c8f7.

36.

Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.

Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, Cross AH.

Neurology. 2009 Jul 7;73(1):46-52. doi: 10.1212/WNL.0b013e3181aaea32.

37.

NMO-IgG detected in CSF in seronegative neuromyelitis optica.

Klawiter EC, Alvarez E 3rd, Xu J, Paciorkowski AR, Zhu L, Parks BJ, Cross AH, Naismith RT.

Neurology. 2009 Mar 24;72(12):1101-3. doi: 10.1212/01.wnl.0000345066.57745.50. No abstract available.

38.

Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis.

Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH.

Neurology. 2009 Mar 24;72(12):1077-82. doi: 10.1212/01.wnl.0000345042.53843.d5.

39.

B cells: no longer the nondominant arm of multiple sclerosis.

Klawiter EC, Cross AH.

Curr Neurol Neurosci Rep. 2007 May;7(3):231-8. Review.

PMID:
17488589

Supplemental Content

Loading ...
Support Center